• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲炎症性肠病临床一致性:疾病初发及第一年在欧洲南北地区的表现。欧洲炎症性肠病研究组

Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group.

作者信息

Lennard-Jones J E, Shivananda S

机构信息

Department of Gastroenterology, St Mark's Hospital, Harrow, UK.

出版信息

Eur J Gastroenterol Hepatol. 1997 Apr;9(4):353-9. doi: 10.1097/00042737-199704000-00007.

DOI:10.1097/00042737-199704000-00007
PMID:9160197
Abstract

OBJECTIVE

To compare the methods used for diagnosis and the clinical features of non-specific inflammatory bowel disease (IBD) in the north and south of Europe.

DESIGN

A prospective study over 2 years in 1991-3 at eight centres in the north and 12 in the south of Europe using the same criteria for disease definition and same protocol for recording data.

SETTING

Specialist gastroenterological centres with good diagnostic facilities at which every effort was made to ascertain all new cases of IBD seen in other departments and primary care in a defined geographical area of known population.

PARTICIPANTS

A total of 2201 patients newly diagnosed as suffering from IBD, 1397 with ulcerative colitis (UC), 706 with Crohn's disease (CD) and 116 with indeterminate colitis (IND).

RESULTS

Diagnostic methods used were similar in north and south, a biopsy or resection specimen was available for examination in 94 and 95%, of cases of UC and 92 and 87% of CD in north and south, respectively. The type, clinical presentation, site and extent of disease were similar in north and south. Treatment followed a common pattern and mortality from IBD was low in the first year after diagnosis. In both areas, age of onset of UC tended to be later than CD.

CONCLUSION

The standard of diagnosis and clinical features of IBD are similar in specialist centres throughout Europe so providing a valid basis for this aspect of collaborative epidemiological or other studies.

摘要

目的

比较欧洲南北部非特异性炎性肠病(IBD)的诊断方法及临床特征。

设计

1991年至1993年在欧洲北部的8个中心和南部的12个中心进行了一项为期2年的前瞻性研究,采用相同的疾病定义标准和相同的数据记录方案。

背景

拥有良好诊断设施的专科胃肠病中心,在已知人口的特定地理区域内,尽一切努力确定在其他科室和初级保健机构中见到的所有IBD新病例。

参与者

共有2201例新诊断为IBD的患者,其中1397例为溃疡性结肠炎(UC),706例为克罗恩病(CD),116例为不确定性结肠炎(IND)。

结果

欧洲南北部使用的诊断方法相似,北部和南部UC病例分别有94%和95%、CD病例分别有92%和87%可获得活检或切除标本以供检查。疾病的类型、临床表现、部位和范围在南北部相似。治疗遵循共同模式,IBD诊断后第一年的死亡率较低。在两个地区,UC的发病年龄往往比CD晚。

结论

欧洲各专科中心IBD的诊断标准和临床特征相似,为协作性流行病学研究或其他研究的这一方面提供了有效依据。

相似文献

1
Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group.欧洲炎症性肠病临床一致性:疾病初发及第一年在欧洲南北地区的表现。欧洲炎症性肠病研究组
Eur J Gastroenterol Hepatol. 1997 Apr;9(4):353-9. doi: 10.1097/00042737-199704000-00007.
2
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.欧洲炎症性肠病发病率的东西梯度:ECCO-EpiCom 起始队列。
Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.
3
Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).欧洲炎症性肠病的发病率:南北之间存在差异吗?欧洲炎症性肠病协作研究(EC-IBD)的结果。
Gut. 1996 Nov;39(5):690-7. doi: 10.1136/gut.39.5.690.
4
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
5
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.炎症性肠病:挪威东南部一项基于前瞻性人群研究的诊断再评估
Gut. 1997 Mar;40(3):328-32. doi: 10.1136/gut.40.3.328.
6
Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective study.意大利北部人群炎症性肠病的流行病学特征:一项为期4年的前瞻性研究。
Eur J Gastroenterol Hepatol. 1996 Jul;8(7):657-61.
7
[Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias].[阿斯图里亚斯希洪市慢性炎症性肠病的流行病学]
Gastroenterol Hepatol. 2001 May;24(5):228-35.
8
Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).
Scand J Gastroenterol. 2000 Dec;35(12):1272-7. doi: 10.1080/003655200453610.
9
Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).炎症性肠病发病后头五年内的诊断变化:一项前瞻性随访研究(IBSEN研究)的结果
Scand J Gastroenterol. 2006 Sep;41(9):1037-43. doi: 10.1080/00365520600554527.
10
Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data.法国炎症性肠病的地理差异:一项基于国家医疗保险数据的研究。
Inflamm Bowel Dis. 2006 Mar;12(3):218-26. doi: 10.1097/01.MIB.0000206540.38834.8c.

引用本文的文献

1
Prevalence, Risk Factors and Association with Clinical Outcomes of Malnutrition and Sarcopenia in Inflammatory Bowel Disease: A Prospective Study.炎症性肠病中营养不良和肌肉减少症的患病率、危险因素及其与临床结局的关联:一项前瞻性研究
Nutrients. 2024 Nov 21;16(23):3983. doi: 10.3390/nu16233983.
2
Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity.伴有炎症性肠病的原发性硬化性胆管炎患者体内抗整合素αvβ6自身抗体增加,且与肝脏疾病严重程度相关。
Clin Gastroenterol Hepatol. 2024 Oct 25. doi: 10.1016/j.cgh.2024.10.005.
3
A High Visceral-to-Skeletal Muscle Area Ratio on Cross-Sectional Imaging Is Associated With Failure of Standard Ustekinumab Doses: A Multicenter Study.
横断面影像学上高内脏到骨骼肌面积比与标准乌司奴单抗剂量失败相关:一项多中心研究。
Clin Transl Gastroenterol. 2024 Jul 1;15(7):e00722. doi: 10.14309/ctg.0000000000000722.
4
Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT).新型生物标志物谱可改善疑似炎症性肠病患者的个体诊断和预后:北欧发病队列研究(NORDTREAT)方案。
BMJ Open. 2024 May 15;14(5):e083144. doi: 10.1136/bmjopen-2023-083144.
5
Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III).炎症性肠病初诊患者的健康相关生活质量:一项观察性前瞻性队列研究(IBSEN III)。
Qual Life Res. 2023 Oct;32(10):2951-2964. doi: 10.1007/s11136-023-03435-9. Epub 2023 May 23.
6
Towards a clinically-based common coordinate framework for the human gut cell atlas: the gut models.迈向基于临床的人类肠道细胞图谱通用坐标框架:肠道模型。
BMC Med Inform Decis Mak. 2023 Feb 15;23(1):36. doi: 10.1186/s12911-023-02111-9.
7
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.抗整合素 αvβ6 自身抗体是一种新型生物标志物,其出现早于溃疡性结肠炎。
Gastroenterology. 2023 Apr;164(4):619-629. doi: 10.1053/j.gastro.2022.12.042. Epub 2023 Jan 10.
8
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease.机器学习识别新诊断的小儿克罗恩病并发穿透性和狭窄性并发症的新型血液蛋白预测因子。
Aliment Pharmacol Ther. 2021 Jan;53(2):281-290. doi: 10.1111/apt.16136. Epub 2020 Nov 1.
9
Atypical Clinical Presentation of Crohn's Disease as Diffuse Abdominal Lymphadenopathy and Venous Thrombosis: A Difficult to Diagnose Case.克罗恩病表现为弥漫性腹部淋巴结病和静脉血栓形成的非典型临床表现:一例难以诊断的病例
Cureus. 2019 Sep 30;11(9):e5805. doi: 10.7759/cureus.5805.
10
ACG Clinical Guideline: Management of Crohn's Disease in Adults.ACG 临床指南:成人克罗恩病的管理。
Am J Gastroenterol. 2018 Apr;113(4):481-517. doi: 10.1038/ajg.2018.27. Epub 2018 Mar 27.